Dr. Barry Dworkin

Adults over 60 in U.S. advised to skip Chikungunya vaccine. What about Canada?

Medical Mythbusting Commentary for May 15, 2025

Source:
Older adults in U.S. urged to skip this travel vaccine. What about Canada?

Reference:
FDA and CDC Recommend Pause in Use of Ixchiq (Chikungunya Vaccine, Live) in Individuals 60 Years of Age and Older While Postmarketing Safety Reports are Investigated

Related posts:

  1. Cancer patient in dire need denied access to her hospital
  2. Lack of buy-in for infant and toddler flu shots
  3. Google flu and the spread of flu in Ottawa
  4. Risk perception: Imagine the reaction if news reported 10,000 deaths from a virus in one month compared to the ebola coverage